🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multi-center, open label, Phase II clinical trial to assess the safety an...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2019-09-16
Trial ID
NCT03931291
Treatments Being Tested
Study to determine the preliminary safety, tolerability, and pharmacokineti...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2021-03-02
Trial ID
NCT04419389
The purpose of this study is to make a preliminary assessment of the effica...
Status
Terminated
Location
Institut Jules Bordet
Start Date
2018-01-18
Trial ID
NCT03391050
Treatments Being Tested
The main purpose of this study is to determine the safe and efficacy of APR...
Status
Unknown
Location
Bruno Quesnel
Start Date
2018-09-15
Trial ID
NCT03588078
Treatments Being Tested
This phase II trial investigates the effect of venetoclax and eprenetapopt ...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2021-11-30
Trial ID
NCT04990778
Treatments Being Tested
This clinical trial is a Phase I, open-label, dose-finding and cohort expan...
Status
Completed
Location
Yale Cancer Center
Start Date
2019-12-13
Trial ID
NCT04214860
Treatments Being Tested
The main purpose of this study is to determine the safe and recommended dos...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2017-05-18
Trial ID
NCT03072043
Treatments Being Tested
The purpose of this study is to make a preliminary assessment of the effica...
Status
Completed
Location
UCLA
Start Date
2014-03
Trial ID
NCT02098343
Treatments Being Tested
The purpose of this study is to make a preliminary assessment of the effica...
Status
Completed
Location
Medische oncologie, Universitair Ziekenhuis Gent
Start Date
2017-07-31
Trial ID
NCT03268382
Treatments Being Tested
The purpose of this study is to determine the highest feasible dose (HFD) o...
Status
Completed
Location
Section of Haematology and Coagulation, Sahlgrenska University Hospital
Start Date
2009-05
Trial ID
NCT00900614
Treatments Being Tested